UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 476

Sortiert nach

Acute Kidney Injury and Mortality in Hospitalized Patients

American journal of nephrology, 2012-01, Vol.35 (4), p.349-355

2012

Volltextzugriff (PDF)

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate

JAMA : the journal of the American Medical Association, 2012-05, Vol.307 (18), p.1941

2012

Volltextzugriff (PDF)

Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease

Kidney international, 2011-05, Vol.79 (10), p.1051-1060

2011

Volltextzugriff (PDF)

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

American journal of nephrology, 2018-01, Vol.47 (1), p.40-47

2018

Volltextzugriff (PDF)

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

American journal of kidney diseases, 2008-08, Vol.52 (2), p.227-234

2008

Volltextzugriff (PDF)

Current and Investigational Therapeutics for Fabry Disease

Kidney international reports, 2020-04, Vol.5 (4), p.407-413

2020

Volltextzugriff (PDF)

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Critical care (London, England), 2007-01, Vol.11 (2), p.R31-R31

2007

Volltextzugriff (PDF)

Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

American journal of kidney diseases, 2016-01, Vol.67 (1), p.62-69

2016

Volltextzugriff (PDF)

Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults

Stroke (1970), 2016-08, Vol.47 (8), p.2017-2024

2016

Volltextzugriff (PDF)

Foot Process Effacement Is an Early Marker of Nephropathy in Young Classic Fabry Patients without Albuminuria

Nephron (2015), 2015-01, Vol.129 (1), p.16-21

2015

Volltextzugriff (PDF)

Chronic Kidney Disease and Risk of Death from Infection

American journal of nephrology, 2011-01, Vol.34 (4), p.330-336

2011

Volltextzugriff (PDF)

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase

PloS one, 2015-08, Vol.10 (8), p.e0134341-e0134341

2015

Volltextzugriff (PDF)

A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm

Orphanet journal of rare diseases, 2021-12, Vol.16 (1), p.518-518, Article 518

2021

Volltextzugriff (PDF)

Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration

Kidney international, 2016-02, Vol.89 (2), p.354-362

2016

Volltextzugriff (PDF)

Association of Waist Circumference and Body Mass Index With All-Cause Mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

American journal of kidney diseases, 2011-08, Vol.58 (2), p.177-185

2011

Volltextzugriff (PDF)

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States

The American journal of medicine, 2003-09, Vol.115 (4), p.291-297

2003

Volltextzugriff (PDF)

Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule

American journal of physiology. Renal physiology, 2004-10, Vol.287 (4), p.F593-F601

2004

Volltextzugriff (PDF)

The global burden of chronic kidney disease: estimates, variability and pitfalls

Nature reviews. Nephrology, 2017-02, Vol.13 (2), p.104

2017

Volltextzugriff (PDF)

Oral Anticoagulants and Risk of Nephropathy

Drug safety, 2015-06, Vol.38 (6), p.527-533

2015

Volltextzugriff (PDF)

Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry

Clinical journal of the American Society of Nephrology, 2010-12, Vol.5 (12), p.2220-2228

2010

Volltextzugriff (PDF)

Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease

Journal of medical genetics, 2022-03, Vol.59 (3), p.287

2022

Volltextzugriff (PDF)

Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study

Molecular genetics and metabolism reports, 2022-06, Vol.31, p.100862-100862, Article 100862

2022

Volltextzugriff (PDF)

High-sensitivity C-reactive protein and risk of sepsis

PloS one, 2013-07, Vol.8 (7), p.e69232-e69232

2013

Volltextzugriff (PDF)

Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors

Journal of the American Society of Nephrology, 2002-05, Vol.13 (5), p.1131-1135

2002

Volltextzugriff (PDF)

Pharmacovigilance and biosimilars: considerations, needs and challenges

Expert opinion on biological therapy, 2013-07, Vol.13 (7), p.1039-1047

2013

Volltextzugriff (PDF)

1 – 25 von 476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(456)
Mit Volltextzugriff
(437)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(329)
Life Sciences & Biomedicine
(316)
Humans
(282)
Male
(152)
Urology & Nephrology
(151)
Female
(148)
Biological And Medical Sciences
(125)
Middle Aged
(110)
Medical Sciences
(101)
Aged
(91)
Adult
(80)
Animals
(73)
Glomerular Filtration Rate
(52)
Risk Factors
(45)
Nephrology. Urinary Tract Diseases
(40)
Chronic Kidney Disease
(33)
Nephrology
(33)
Fundamental And Applied Biological Sciences. Psychology
(32)
Cohort Studies
(29)
Adolescent
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Acute Kidney Injury and Mortality in Hospitalized Patients

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate

Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

Kidney Function and Cognitive Impairment in US Adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Current and Investigational Therapeutics for Fabry Disease

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults

Foot Process Effacement Is an Early Marker of Nephropathy in Young Classic Fabry Patients without Albuminuria

Chronic Kidney Disease and Risk of Death from Infection

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase

A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm

Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration

Association of Waist Circumference and Body Mass Index With All-Cause Mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States

Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule

The global burden of chronic kidney disease: estimates, variability and pitfalls

Oral Anticoagulants and Risk of Nephropathy

Prognostic Indicators of Renal Disease Progression in Adults with Fabry Disease: Natural History Data from the Fabry Registry

Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease

Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study

High-sensitivity C-reactive protein and risk of sepsis

Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT1 receptors

Pharmacovigilance and biosimilars: considerations, needs and challenges

Suchergebnisse filtern